Health · Medical Research · 2 hrs ago
Mediac Registers Patent for Material That Absorbs DHT Linked to Hair Loss
South Korean company Mediac has registered a patent for a new material designed to absorb dihydrotestosterone, or DHT, a hormone linked to hereditary hair loss.
DHT forms when the body converts testosterone, and it can shrink hair follicles and shorten the hair-growth phase.
Unlike some hair-loss medicines that affect hormone production, the material is designed to capture DHT that already exists.
It uses a porous structure called a metal-organic framework, or MOF, whose pores and surface can be adjusted to interact with particular molecules.
Its real-world effectiveness and safety have not yet been established, so the material is still at an early stage of development.
Mediac is working to adapt it for scalp-care products under its DermaMof brand, while also planning research with pharmaceutical companies on possible drug development applications.
Mediac said it developed and registered a patent for a MOF-based material designed to absorb dihydrotestosterone (DHT), a hormone involved in hereditary hair loss.
The material is designed to capture DHT molecules that have already formed, rather than suppressing DHT production.
Mediac is refining the technology for use in scalp-care products.
The material’s effectiveness in managing hair loss and its safety still require further verification.
The company plans to develop the technology for its Dermamorf brand and explore joint research with pharmaceutical companies.
- Who
- Mediac, a company developing the material.
- What
- It developed and registered a patent for a MOF-based material designed to absorb DHT.
- When
- Mediac announced this on October 26, 2026.
- Where
- Not stated.
- Why
- The company aims to develop the material for scalp-care products and provide another option for people concerned about hair loss.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Material
- MOF-based material designed to absorb DHT
- Target molecule
- Dihydrotestosterone (DHT)
- Patent
- Related patent registered
- Development status
- Effectiveness and safety require further verification
- Planned brand
- Dermamorf
1 source
What people are saying
As the value of MOFs has been highlighted globally through the 2025 Nobel Prize in Chemistry, it is important to apply advanced materials to everyday life.
We will continue research and development so that we can objectively verify the technology’s performance and safety and provide a new option for consumers concerned about hair loss.